← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1996First marketed drug
Aug 10, 2001First NDA
Aug 10, 2001Last known activity
Mar 1, 2008
Acquired by Johnson and Johnson on Jan 1, 2003
Timeline
1980s
- Jan 1, 1981
Scios— Founded
2000s
- Aug 10, 2001
nesiritide— NDA Organization
- Aug 10, 2001
nesiritide— NDA Secondary Org
- Jan 1, 2003
Johnson and Johnson— Acquired By
Drugs by trial phase (8 distinct, 33 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Approved for
Studied for
- Acute Coronary Syndrome
- Acute Kidney Injury
- Arthritis
- Arthritis, Rheumatoid
- Bone Marrow Diseases
- Bone Marrow Neoplasms
- Cardiomyopathies
- Coronary Artery Disease
- Coronary Disease
- Dyspnea
- Emergencies
- Heart Diseases
- Heart Failure
- Heart Failure, Diastolic
- Hematologic Diseases
- Kidney Diseases
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Neoplasms, Plasma Cell
- Preleukemia
- Pulmonary Edema
- Renal Insufficiency
- Syndrome
- Ventricular Dysfunction, Left
Marketed drugs (1)
Recent trials (50)
- NCT00405548CollaboratorPhase 1/Phase 2Mar 1, 2008
- NCT00530361Study directorPhase 3Sep 13, 2007
- NCT00530361Lead sponsorPhase 3Sep 13, 2007
- NCT00505791CollaboratorPhase 4Aug 1, 2007
- NCT00508768Study directorPhase 1Jul 27, 2007
- NCT00508768Lead sponsorPhase 1Jul 27, 2007
- NCT00475852Study directorPhase 3May 1, 2007
- NCT00475852Lead sponsorPhase 3May 1, 2007
- NCT00453453CollaboratorPhase 4Mar 1, 2007
- NCT00338455Study directorPhase 2Sep 1, 2006
- NCT00338455Lead sponsorPhase 2Sep 1, 2006
- NCT00204984CollaboratorN/AMay 1, 2005
- NCT00113893Study directorPhase 2May 1, 2005
- NCT00113893Lead sponsorPhase 2May 1, 2005
- NCT00204945CollaboratorN/AFeb 1, 2005
Details
- Founded
- Sunnyvale, CA, US Jan 1, 1981
- First NDA
- Aug 10, 2001
- Last known activity
- Mar 1, 2008
Notes
Acquired by Johnson and Johnson